Intriguingly, shRNA-mediated silencing of METTL3 in HSPCs of human AML promotes HSPC differentiation by increasing p-AKT levels and facilitates apoptosis by promoting the mRNA translation of c-MYC, BCL2, and PTEN while inhibiting proliferation. Here, METTL3 is linked to acute myeloid leukemia.